CA
NZ
UK
AU
IND
US
BioCardia, Inc. (NASDAQ: BCDA) has received confirmation from the FDA regarding the meeting minutes pertaining to the Helix Transendocardial Delivery Catheter System, following the recent FDA pre-submission meeting. This confirmation, released on August 24, 2026, solidifies the company's previous communications with the agency, including …
The outcome highlights both the risks of ongoing litigation and Cytek Biosciences, Inc. (NASDAQ: CTKB)'s ability to defend its intellectual property amidst complex legal challenges.
EBR Systems, Inc. announced the impending departure of its Chief Commercial Officer, Erik Strandberg, set to leave the company in the coming months. The specific date of his exit has not been finalized. The transition will not stem from any disagreements regarding the company's …
Abbott's Revenue Surged to $3.09 Billion
REGENXBIO Inc. (NASDAQ:RGNX) shares fell 24.86% to $8.06 in the latest closing session, placing the stock among the day's most notable decliners.
Lantern Pharma Inc. (NASDAQ:LTRN) shares fell 9.83% to $2.11 in the latest closing session, placing the stock among the day's most notable decliners.
Haoxi Health Technology Ltd (NASDAQ:HAO) shares fell 7.95% to $3.01 in the latest closing session, placing the stock among the day's most notable decliners.
Hims & Hers Health, Inc. (NYSE:HIMS) shares fell 8.01% to $31.08 in the latest closing session, placing the stock among the day's most notable decliners.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares have been among the more volatile names onNasdaqthis month, with the stock falling 8.46% to $4.87 in the latest closing session and sitting near the low end of a 52-week range that stretches from $19.01 to $3.95.
CDT Equity Inc. (NASDAQ:CDT), formerly Conduit Pharmaceuticals Inc., saw shares fall 12.94% to $2.49 in the latest closing session, placing the stock among the day's most notable decliners.
Please wait processing your request...